1. Home
  2. ELWT vs RNTX Comparison

ELWT vs RNTX Comparison

Compare ELWT & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ELWT

Elauwit Connection Inc.

N/A

Current Price

$6.12

Market Cap

40.6M

ML Signal

N/A

RNTX

Rein Therapeutics Inc.

N/A

Current Price

$1.63

Market Cap

42.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELWT
RNTX
Founded
2002
2001
Country
United States
United States
Employees
34
10
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.6M
42.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ELWT
RNTX
Price
$6.12
$1.63
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$12.00
$10.00
AVG Volume (30 Days)
39.7K
114.9K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$167.76
N/A
Revenue Next Year
$22.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.11
$1.02
52 Week High
$8.25
$2.22

Technical Indicators

Market Signals
Indicator
ELWT
RNTX
Relative Strength Index (RSI) 50.22 68.31
Support Level $6.30 $1.08
Resistance Level $7.10 $2.18
Average True Range (ATR) 0.71 0.18
MACD -0.04 0.03
Stochastic Oscillator 58.26 89.83

Price Performance

Historical Comparison
ELWT
RNTX

About ELWT Elauwit Connection Inc.

Elauwit Connection Inc is a provider of broadband Internet networks for the multifamily and student housing property sector. It designs, installs, operates, and maintains new fiber-optic and WiFi networks throughout each contracted property. Once installed, property owners begin selling Internet connectivity over Elauwit's network directly to their residents at monthly prices and terms of their choosing. Elauwit, in turn, provides all resident activation, onboarding, customer support, and network monitoring and maintenance services in exchange for a fixed monthly fee based on the number of units in the property times a monthly per-unit wholesale price. Its contracts with property owners generally have five to eight-year terms. Geographically, the company mainly operates in the U.S.

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

Share on Social Networks: